| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $127.8M | -9.9% |
| Cost of Revenue | $19.6M | -3.1% |
| R&D Expense | $12.8M | -32.0% |
| SG&A Expense | $27.1M | -9.8% |
| Operating Income | -$11.4M | -279.8% |
| Interest Expense | $2.5M | -23.2% |
| Pre-tax Income | -$14.7M | -597.9% |
| Income Tax | -$1.2M | -143.7% |
| Net Income | -$13.5M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $2.9M | -21.4% |
| Accounts Receivable | $18.0M | -18.8% |
| Current Assets | $24.5M | -17.4% |
| Total Assets | $188.2M | -15.0% |
| Current Liabilities | $55.1M | -12.2% |
| Long-term Debt | $30.0M | -6.3% |
| Total Liabilities | $93.7M | -12.4% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $21.1M | +0.3% |
| Capital Expenditures | $7.3M | -47.5% |
| Investing Cash Flow | -$8.7M | +37.5% |
| Financing Cash Flow | -$13.2M | -73.1% |
| Free Cash Flow | $13.8M | +93.9% |
| -5439.9% |
| EPS (Basic) | -$0.30 | -3100.0% |
| EPS (Diluted) | -$0.30 | -3100.0% |
| Stockholders' Equity |
| $94.5M |
| -17.3% |